CYIENT LTD. (INVESTOR DAY HIGHLIGHTS & BROKERAGE OUTLOOK)

1. Executive Summary & Market Reaction Cyient Ltd. shares experienced a 4% jump following the company's investor day presentation, where it outlined growth and margin priorities. PDF The stock closed at ₹975.05 on Tuesday, reflecting a gain of more than 18% over the past month. 2. Strategic Roadmap & Financial Targets Growth Trajectory: The company is prioritizing near-term revenue re-acceleration, targeting double-digit year-on-year growth and steady quarter-on-quarter expansion through FY28-29. Management described FY26 as a stabilization year, with FY27 and FY28 marking a recovery phase driven by a revamped strategy. Margin Expansion: Cyient aims for near-term EBIT margins exceeding 15% and medium- to long-term margins of over 16%. The company has already improved its EBIT margin to 13.2% in Q1 FY27, up from around 12.2%, aiming to reach its 15% target through AI-led revenue leverage and operating cost efficiencies. Business Model Pivot: A newly structured go-to-market (GTM) team is shifting focus from project-based work (currently ~40% of the business) toward predictable, annuity-based contracts and larger deals. Deal Pipeline: Management confirmed the large-deal pipeline is at a record high, comprising nine qualified deals with an estimated total contract value of $300 million. 3. Institutional & Brokerage Consensus JPMorgan ('Overweight' | Target: ₹1,050): The brokerage cited the shift toward annuity-based revenue, large-deal focus, and margin expansion plans as key positives, noting that execution will be the primary catalyst for a stock re-rating. Emkay Global ('Reduce' | Target: ₹900): Emkay noted that management has addressed key growth impediments and put strategic levers in place, but awaits concrete execution before changing its rating.